FGF2 Human (+)-pilocarpine multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 FGF2 inhibits the reaction [Pilocarpine results in increased expression of IL1B protein] CTD PMID:21087489 FGF2 Human (-)-epigallocatechin 3-gallate decreases expression EXP 6480464 epigallocatechin gallate results in decreased expression of FGF2 mRNA CTD PMID:16084531 FGF2 Human (-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FGF2 mRNA CTD PMID:22079256 FGF2 Human (R)-noradrenaline multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 [AVP protein co-treated with Norepinephrine] inhibits the reaction [Triiodothyronine promotes the reaction [FGF2 protein results in increased expression of UCP1 mRNA]] CTD PMID:11742803 FGF2 Human (S)-colchicine affects expression ISO Fgf2 (Rattus norvegicus) 6480464 Colchicine affects the expression of FGF2 protein CTD PMID:7714246 FGF2 Human (S)-nicotine decreases expression ISO Fgf2 (Rattus norvegicus) 6480464 Nicotine results in decreased expression of FGF2 protein CTD PMID:14732461 FGF2 Human (S)-nicotine increases expression ISO Fgf2 (Mus musculus) 6480464 Nicotine results in increased expression of FGF2 mRNA and Nicotine results in increased expression of FGF2 protein CTD PMID:31622651 and PMID:32512034 FGF2 Human (S)-nicotine increases expression ISO Fgf2 (Rattus norvegicus) 6480464 Nicotine results in increased expression of FGF2 mRNA and Nicotine results in increased expression of FGF2 protein CTD PMID:15465631 more ... FGF2 Human (S)-nicotine increases secretion EXP 6480464 Nicotine results in increased secretion of FGF2 protein CTD PMID:16365874 and PMID:22198237 FGF2 Human (S)-nicotine multiple interactions EXP 6480464 [triethyl-(beta-4-stilbenoxyethyl)ammonium inhibits the reaction [Nicotine promotes the reaction [EGR1 protein binds to FGF2 promoter]]] which results in decreased expression of FGF2 mRNA more ... CTD PMID:22198237 FGF2 Human (S)-nicotine multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 Mecamylamine inhibits the reaction [Nicotine results in increased expression of FGF2 mRNA] and triethyl-(beta-4-stilbenoxyethyl)ammonium inhibits the reaction [Nicotine results in increased expression of FGF2 mRNA] CTD PMID:22198237 and PMID:9832142 FGF2 Human 1,2-dimethylhydrazine multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 p-coumaric acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of FGF2 protein] CTD PMID:29879413 FGF2 Human 1,2-dimethylhydrazine increases expression ISO Fgf2 (Rattus norvegicus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of FGF2 protein CTD PMID:29879413 FGF2 Human 1-(5-isoquinolinesulfonyl)-2-methylpiperazine multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Dinoprost affects the localization of FGF2 protein] CTD PMID:15654655 FGF2 Human 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine decreases expression ISO Fgf2 (Mus musculus) 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:28801915 FGF2 Human 1-naphthyl isothiocyanate multiple interactions EXP 6480464 [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of FGF2 mRNA CTD PMID:27344345 FGF2 Human 14,15-EET increases expression EXP 6480464 14 more ... CTD PMID:16286479 FGF2 Human 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of FGF2 mRNA CTD PMID:21098263 FGF2 Human 17beta-estradiol multiple interactions EXP 6480464 [Estradiol binds to ESR2 protein] which results in decreased expression of FGF2 mRNA and [Progesterone co-treated with Estradiol] results in increased expression of FGF2 mRNA CTD PMID:18692832 and PMID:20404318 FGF2 Human 17beta-hydroxy-5alpha-androstan-3-one increases expression EXP 6480464 Dihydrotestosterone results in increased expression of FGF2 mRNA and Dihydrotestosterone results in increased expression of FGF2 protein CTD PMID:20421132 FGF2 Human 17beta-hydroxy-5alpha-androstan-3-one multiple interactions EXP 6480464 Flutamide inhibits the reaction [Dihydrotestosterone results in increased expression of FGF2 mRNA] and Flutamide inhibits the reaction [Dihydrotestosterone results in increased expression of FGF2 protein] CTD PMID:20421132 FGF2 Human 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions ISO Fgf2 (Mus musculus) 6480464 2 more ... CTD PMID:23564643 FGF2 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Fgf2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of FGF2 mRNA CTD PMID:12167310 FGF2 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of FGF2 mRNA CTD PMID:36370075 FGF2 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of FGF2 mRNA CTD PMID:12377990 more ... FGF2 Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of FGF2 mRNA] CTD PMID:23625689 FGF2 Human 2,3,7,8-tetrachlorodibenzodioxine decreases activity ISO Fgf2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased activity of FGF2 protein CTD PMID:20486776 and PMID:23212921 FGF2 Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Fgf2 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin analog co-treated with FGF2 protein] results in increased expression of DSG1A mRNA more ... CTD PMID:23212921 FGF2 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Fgf2 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of FGF2 mRNA CTD PMID:21724226 FGF2 Human 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO Fgf2 (Rattus norvegicus) 6480464 2 more ... CTD PMID:21724226 FGF2 Human 2-amino-2-deoxy-D-glucopyranose multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 Glucosamine promotes the reaction [Glucose results in increased expression of FGF2 mRNA] CTD PMID:1518840 FGF2 Human 2-hydroxyethyl methacrylate multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [hydroxyethyl methacrylate results in increased secretion of FGF2 protein] and pyrazolanthrone inhibits the reaction [hydroxyethyl methacrylate results in increased secretion of FGF2 protein] CTD PMID:19176594 FGF2 Human 2-hydroxyethyl methacrylate increases secretion EXP 6480464 hydroxyethyl methacrylate results in increased secretion of FGF2 protein CTD PMID:19176594 FGF2 Human 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO Fgf2 (Rattus norvegicus) 6480464 3 more ... CTD PMID:23196670 FGF2 Human 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:35618242 FGF2 Human 3,3',5-triiodo-L-thyronine multiple interactions ISO Fgf2 (Mus musculus) 6480464 Triiodothyronine inhibits the reaction [FGF2 protein results in increased phosphorylation of STAT1 protein] more ... CTD PMID:16150908 FGF2 Human 3,3',5-triiodo-L-thyronine multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 [AVP protein co-treated with Norepinephrine] inhibits the reaction [Triiodothyronine promotes the reaction [FGF2 protein results in increased expression of UCP1 mRNA]] more ... CTD PMID:11742803 and PMID:12805413 FGF2 Human 3,4-dihydroxybenzaldehyde multiple interactions EXP 6480464 protocatechualdehyde inhibits the reaction [TGFB1 protein results in increased expression of FGF2 protein] CTD PMID:25582705 FGF2 Human 3,4-dihydroxybenzaldehyde multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 protocatechualdehyde inhibits the reaction [Bleomycin results in increased expression of FGF2 protein] CTD PMID:25582705 FGF2 Human 3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 bisindolylmaleimide I promotes the reaction [FGF2 protein results in increased expression of UCP1 mRNA] CTD PMID:11742803 FGF2 Human 3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione multiple interactions ISO Fgf2 (Mus musculus) 6480464 bisindolylmaleimide I inhibits the reaction [FGF2 protein results in increased expression of RUNX2 mRNA] CTD PMID:12403780 FGF2 Human 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO Fgf2 (Mus musculus) 6480464 [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FGF2 protein more ... CTD PMID:28285642 FGF2 Human 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [Bucladesine co-treated with 1-Methyl-3-isobutylxanthine co-treated with EGF protein co-treated with FGF2 protein co-treated with NGF protein co-treated with BDNF protein] results in increased expression of ENO2 mRNA more ... CTD PMID:29698629 FGF2 Human 3-Nitrobenzanthrone increases expression EXP 6480464 3-nitrobenzanthrone results in increased expression of FGF2 mRNA CTD PMID:34036453 FGF2 Human 3H-1,2-dithiole-3-thione increases expression ISO Fgf2 (Rattus norvegicus) 6480464 1 and 2-dithiol-3-thione results in increased expression of FGF2 mRNA CTD PMID:19162173 FGF2 Human 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol S co-treated with Fulvestrant] results in increased methylation of FGF2 gene CTD PMID:31601247 FGF2 Human 4-hydroxyphenyl retinamide decreases expression ISO Fgf2 (Mus musculus) 6480464 Fenretinide results in decreased expression of FGF2 mRNA CTD PMID:28973697 FGF2 Human 4-phenylbutyric acid decreases expression EXP 6480464 4-phenylbutyric acid results in decreased expression of FGF2 mRNA CTD PMID:14583596 FGF2 Human 5-(2-methylpiperazine-1-sulfonyl)isoquinoline multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Dinoprost affects the localization of FGF2 protein] CTD PMID:15654655 FGF2 Human 5-fluorouracil decreases expression EXP 6480464 Fluorouracil results in decreased expression of FGF2 mRNA CTD PMID:16510598 FGF2 Human 6-aminonicotinamide multiple interactions ISO Fgf2 (Mus musculus) 6480464 IL6 protein promotes the reaction [6-Aminonicotinamide results in increased expression of FGF2 protein] CTD PMID:12898533 FGF2 Human 6-aminonicotinamide increases expression ISO Fgf2 (Mus musculus) 6480464 6-Aminonicotinamide results in increased expression of FGF2 protein CTD PMID:12898533 FGF2 Human 6-propyl-2-thiouracil decreases expression ISO Fgf2 (Rattus norvegicus) 6480464 Propylthiouracil results in decreased expression of FGF2 mRNA CTD PMID:24780913 and PMID:33150595 FGF2 Human 6-propyl-2-thiouracil increases methylation ISO Fgf2 (Rattus norvegicus) 6480464 Propylthiouracil results in increased methylation of FGF2 promoter CTD PMID:33150595 FGF2 Human acrolein multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of FGF2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of FGF2 mRNA CTD PMID:32699268 FGF2 Human acrylamide multiple interactions EXP 6480464 Acrylamide analog inhibits the reaction [Trifluoroacetic Acid results in increased degradation of FGF2 protein] and Acrylamide analog promotes the reaction [FGF2 protein binds to FGF2 protein] CTD PMID:14733594 FGF2 Human actinomycin D multiple interactions EXP 6480464 Dactinomycin inhibits the reaction [Sodium Chloride results in increased expression of FGF2 mRNA] CTD PMID:26800359 FGF2 Human actinomycin D multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 Dactinomycin inhibits the reaction [FGF2 protein results in increased expression of SNCA protein] CTD PMID:12562524 FGF2 Human actinomycin D decreases expression EXP 6480464 Dactinomycin results in decreased expression of FGF2 mRNA CTD PMID:26800359 FGF2 Human aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of FGF2 mRNA CTD PMID:27153756 FGF2 Human albuterol multiple interactions EXP 6480464 [Beclomethasone co-treated with Albuterol] inhibits the reaction [FGF2 protein results in increased secretion of FN1 protein] more ... CTD PMID:18076728 FGF2 Human aldehydo-D-glucosamine multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 Glucosamine promotes the reaction [Glucose results in increased expression of FGF2 mRNA] CTD PMID:1518840 FGF2 Human aldehydo-D-glucose increases expression ISO Fgf2 (Rattus norvegicus) 6480464 Glucose results in increased expression of FGF2 mRNA and Glucose results in increased expression of FGF2 protein CTD PMID:1518840 and PMID:19759273 FGF2 Human aldehydo-D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of FGF2 mRNA CTD PMID:31655124 FGF2 Human aldehydo-D-glucose multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 Glucosamine promotes the reaction [Glucose results in increased expression of FGF2 mRNA] CTD PMID:1518840 FGF2 Human all-trans-retinoic acid multiple interactions ISO Fgf2 (Mus musculus) 6480464 FGF2 protein promotes the reaction [Tretinoin results in increased expression of GAB2 protein] more ... CTD PMID:16009726 FGF2 Human all-trans-retinoic acid decreases expression ISO Fgf2 (Rattus norvegicus) 6480464 Tretinoin results in decreased expression of FGF2 mRNA CTD PMID:20488242 FGF2 Human all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of FGF2 mRNA CTD PMID:21934132 FGF2 Human all-trans-retinoic acid decreases response to substance ISO Fgf2 (Rattus norvegicus) 6480464 Tretinoin results in decreased susceptibility to FGF2 protein CTD PMID:11675954 FGF2 Human all-trans-retinoic acid multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 Tretinoin inhibits the reaction [FGF2 protein results in increased expression of CCND3 mRNA] more ... CTD PMID:11675954 FGF2 Human all-trans-retinoic acid decreases response to substance ISO Fgf2 (Mus musculus) 6480464 FGF2 protein results in decreased susceptibility to Tretinoin CTD PMID:16009726 FGF2 Human alliin decreases secretion EXP 6480464 alliin results in decreased secretion of FGF2 protein CTD PMID:16351512 FGF2 Human alliin multiple interactions EXP 6480464 alliin promotes the reaction [FGF2 protein results in increased expression of TP53 protein] CTD PMID:16351512 FGF2 Human alpha-D-galactose multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 Alpinia oxyphylla fruit extract inhibits the reaction [Galactose results in increased expression of FGF2 protein] CTD PMID:30367734 FGF2 Human alpha-D-galactose increases expression ISO Fgf2 (Rattus norvegicus) 6480464 Galactose results in increased expression of FGF2 protein CTD PMID:30367734 FGF2 Human alpha-naphthoflavone multiple interactions EXP 6480464 alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein]] and alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK3 protein]] CTD PMID:20876236 FGF2 Human alpha-pinene multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of FGF2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of FGF2 mRNA CTD PMID:32699268 FGF2 Human ammonium chloride affects expression ISO Fgf2 (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of FGF2 mRNA CTD PMID:16483693 FGF2 Human amphetamine increases expression ISO Fgf2 (Rattus norvegicus) 6480464 Amphetamine results in increased expression of FGF2 protein CTD PMID:16338078 FGF2 Human amphetamine affects expression ISO Fgf2 (Rattus norvegicus) 6480464 Amphetamine affects the expression of FGF2 protein CTD PMID:10854759 FGF2 Human anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [hydroxyethyl methacrylate results in increased secretion of FGF2 protein] more ... CTD PMID:12832416 more ... FGF2 Human anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 pyrazolanthrone inhibits the reaction [diphenylarsinic acid results in increased secretion of FGF2 protein] CTD PMID:28087833 FGF2 Human anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO Fgf2 (Mus musculus) 6480464 pyrazolanthrone inhibits the reaction [FGF2 protein results in increased secretion of TNFRSF11B protein] CTD PMID:25290095 FGF2 Human antimycin A increases expression EXP 6480464 Antimycin A results in increased expression of FGF2 mRNA CTD PMID:33512557 FGF2 Human apigenin multiple interactions EXP 6480464 Apigenin inhibits the reaction [Sodium Chloride results in increased expression of FGF2 mRNA] CTD PMID:26800359 FGF2 Human aristolochic acid A decreases expression EXP 6480464 aristolochic acid I results in decreased expression of FGF2 mRNA CTD PMID:33212167 FGF2 Human arsane decreases expression ISO Fgf2 (Mus musculus) 6480464 Arsenic results in decreased expression of FGF2 mRNA CTD PMID:24019935 FGF2 Human arsane affects methylation EXP 6480464 Arsenic affects the methylation of FGF2 gene CTD PMID:25304211 FGF2 Human arsenic atom decreases expression ISO Fgf2 (Mus musculus) 6480464 Arsenic results in decreased expression of FGF2 mRNA CTD PMID:24019935 FGF2 Human arsenic atom affects methylation EXP 6480464 Arsenic affects the methylation of FGF2 gene CTD PMID:25304211 FGF2 Human arsenite(3-) increases expression ISO Fgf2 (Mus musculus) 6480464 arsenite results in increased expression of FGF2 mRNA CTD PMID:15345372 FGF2 Human arsenous acid multiple interactions EXP 6480464 Arsenic Trioxide inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein] and Arsenic Trioxide inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK3 protein] CTD PMID:15723287 FGF2 Human arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of FGF2 mRNA CTD PMID:22521957 FGF2 Human atrazine increases expression ISO Fgf2 (Rattus norvegicus) 6480464 Atrazine results in increased expression of FGF2 mRNA CTD PMID:36841081 FGF2 Human Azoxymethane multiple interactions ISO Fgf2 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FGF2 mRNA CTD PMID:29950665 FGF2 Human bathocuproine disulfonic acid multiple interactions ISO Fgf2 (Mus musculus) 6480464 bathocuproine sulfonate inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein] and bathocuproine sulfonate inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK3 protein] CTD PMID:22842628 FGF2 Human BAY 60-6583 multiple interactions ISO Fgf2 (Mus musculus) 6480464 1-propyl-8-(4-sulfophenyl)xanthine inhibits the reaction [BAY 60-6583 results in increased expression of FGF2 protein] and [BAY 60-6583 co-treated with cobaltous chloride] results in increased expression of FGF2 protein CTD PMID:27590504 FGF2 Human BAY 60-6583 increases expression ISO Fgf2 (Mus musculus) 6480464 BAY 60-6583 results in increased expression of FGF2 protein CTD PMID:27590504 FGF2 Human beclomethasone multiple interactions EXP 6480464 [Beclomethasone co-treated with Albuterol] inhibits the reaction [FGF2 protein results in increased secretion of FN1 protein] more ... CTD PMID:18076728 FGF2 Human beclomethasone decreases activity EXP 6480464 Beclomethasone results in decreased activity of FGF2 protein CTD PMID:18076728 FGF2 Human benzalkonium chloride affects response to substance EXP 6480464 FGF2 SNP affects the susceptibility to Benzalkonium Compounds CTD PMID:27206134 FGF2 Human benzene increases expression ISO Fgf2 (Mus musculus) 6480464 Benzene results in increased expression of FGF2 mRNA CTD PMID:37084897 FGF2 Human benzo[a]pyrene multiple interactions EXP 6480464 alpha-naphthoflavone inhibits the reaction [Benzo(a)pyrene inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein]] more ... CTD PMID:20876236 FGF2 Human benzo[a]pyrene affects methylation EXP 6480464 Benzo(a)pyrene affects the methylation of FGF2 intron and Benzo(a)pyrene affects the methylation of FGF2 promoter CTD PMID:27901495 and PMID:30157460 FGF2 Human benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of FGF2 mRNA CTD PMID:19181443 FGF2 Human benzo[a]pyrene decreases response to substance EXP 6480464 Benzo(a)pyrene results in decreased susceptibility to FGF2 protein CTD PMID:20876236 FGF2 Human beta-D-glucosamine multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 Glucosamine promotes the reaction [Glucose results in increased expression of FGF2 mRNA] CTD PMID:1518840 FGF2 Human bis(2-ethylhexyl) phthalate multiple interactions ISO Fgf2 (Mus musculus) 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of FGF2 mRNA CTD PMID:37021957 FGF2 Human bis(2-ethylhexyl) phthalate increases expression ISO Fgf2 (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of FGF2 mRNA CTD PMID:34319233 FGF2 Human bisphenol A decreases expression ISO Fgf2 (Mus musculus) 6480464 bisphenol A results in decreased expression of FGF2 mRNA CTD PMID:27022677 FGF2 Human bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FGF2 protein CTD PMID:37567409 FGF2 Human bisphenol A decreases methylation EXP 6480464 bisphenol A results in decreased methylation of FGF2 gene CTD PMID:31601247 FGF2 Human bisphenol A increases methylation ISO Fgf2 (Rattus norvegicus) 6480464 bisphenol A results in increased methylation of FGF2 gene CTD PMID:28505145 FGF2 Human bisphenol A decreases expression ISO Fgf2 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of FGF2 mRNA CTD PMID:25181051 and PMID:34947998 FGF2 Human bleomycin A2 increases expression ISO Fgf2 (Rattus norvegicus) 6480464 Bleomycin results in increased expression of FGF2 protein CTD PMID:25582705 FGF2 Human bleomycin A2 multiple interactions ISO Fgf2 (Mus musculus) 6480464 Cannabidiol analog promotes the reaction [Bleomycin results in increased expression of FGF2 protein] CTD PMID:30825431 FGF2 Human bleomycin A2 increases expression ISO Fgf2 (Mus musculus) 6480464 Bleomycin results in increased expression of FGF2 protein CTD PMID:30825431 FGF2 Human bleomycin A2 multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 protocatechualdehyde inhibits the reaction [Bleomycin results in increased expression of FGF2 protein] CTD PMID:25582705 FGF2 Human boric acid multiple interactions ISO Fgf2 (Mus musculus) 6480464 boric acid promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FGF2 protein] CTD PMID:28285642 FGF2 Human bucladesine multiple interactions EXP 6480464 [Bucladesine co-treated with 1-Methyl-3-isobutylxanthine co-treated with EGF protein co-treated with FGF2 protein co-treated with NGF protein co-treated with BDNF protein] results in increased expression of ENO2 mRNA more ... CTD PMID:29698629 FGF2 Human Butylbenzyl phthalate multiple interactions ISO Fgf2 (Mus musculus) 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of FGF2 mRNA CTD PMID:37021957 FGF2 Human C60 fullerene decreases expression ISO Fgf2 (Rattus norvegicus) 6480464 fullerene C60 results in decreased expression of FGF2 mRNA CTD PMID:19167457 FGF2 Human cadmium atom decreases expression EXP 6480464 Cadmium results in decreased expression of FGF2 mRNA CTD PMID:20570719 FGF2 Human cadmium atom multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FGF2 mRNA CTD PMID:35301059 FGF2 Human cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FGF2 mRNA CTD PMID:35301059 FGF2 Human Calcitonin gene-related peptide 1 increases expression ISO Fgf2 (Rattus norvegicus) 329849008 calcitonin gene-related peptide increases expression of mRNA in rat brain after middle cerebral artery infarction RGD FGF2 Human Calphostin C multiple interactions ISO Fgf2 (Mus musculus) 6480464 calphostin C inhibits the reaction [FGF2 protein results in increased expression of and results in increased activity of RUNX2 protein] and calphostin C inhibits the reaction [FGF2 protein results in increased expression of RUNX2 mRNA] CTD PMID:12403780 FGF2 Human cannabidiol multiple interactions ISO Fgf2 (Mus musculus) 6480464 Cannabidiol analog promotes the reaction [Bleomycin results in increased expression of FGF2 protein] CTD PMID:30825431 FGF2 Human cannabidiol increases expression EXP 6480464 Cannabidiol results in increased expression of FGF2 mRNA CTD PMID:27918106 and PMID:36519830 FGF2 Human capsaicin decreases expression ISO Fgf2 (Rattus norvegicus) 6480464 Capsaicin results in decreased expression of FGF2 protein CTD PMID:14521749 FGF2 Human carbon nanotube increases expression ISO Fgf2 (Mus musculus) 6480464 Nanotubes and Carbon results in increased expression of FGF2 mRNA CTD PMID:25554681 FGF2 Human carmustine decreases response to substance EXP 6480464 FGF2 protein results in decreased susceptibility to Carmustine CTD PMID:20221717 FGF2 Human cerivastatin decreases expression ISO Fgf2 (Rattus norvegicus) 6480464 cerivastatin results in decreased expression of FGF2 mRNA and cerivastatin results in decreased expression of FGF2 protein CTD PMID:11479256 FGF2 Human chlorpromazine multiple interactions EXP 6480464 [Chlorpromazine co-treated with Cholic Acids] affects the expression of FGF2 mRNA CTD PMID:27344345 FGF2 Human chlorpyrifos decreases expression ISO Fgf2 (Rattus norvegicus) 6480464 Chlorpyrifos results in decreased expression of FGF2 mRNA CTD PMID:17589599 FGF2 Human chondroitin sulfate affects binding EXP 6480464 [Chondroitin Sulfates binds to Dermatan Sulfate] which binds to FGF2 protein and Chondroitin Sulfates analog binds to FGF2 protein CTD PMID:12221095 and PMID:15385557 FGF2 Human cilazapril monohydrate decreases expression ISO Fgf2 (Rattus norvegicus) 6480464 Cilazapril results in decreased expression of FGF2 mRNA and Cilazapril results in decreased expression of FGF2 protein CTD PMID:9640960 FGF2 Human cilnidipine decreases expression ISO Fgf2 (Rattus norvegicus) 6480464 cilnidipine results in decreased expression of FGF2 mRNA CTD PMID:16333380 FGF2 Human cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of FGF2 mRNA more ... CTD PMID:21858171 more ... FGF2 Human cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of FGF2 mRNA CTD PMID:27392435 FGF2 Human clozapine increases expression ISO Fgf2 (Rattus norvegicus) 6480464 Clozapine results in increased expression of FGF2 mRNA CTD PMID:11264663 FGF2 Human cobalt dichloride multiple interactions ISO Fgf2 (Mus musculus) 6480464 [BAY 60-6583 co-treated with cobaltous chloride] results in increased expression of FGF2 protein CTD PMID:27590504 FGF2 Human cocaine decreases expression EXP 6480464 Cocaine results in decreased expression of FGF2 mRNA CTD PMID:12629581 FGF2 Human colforsin daropate hydrochloride increases expression EXP 6480464 Colforsin results in increased expression of FGF2 mRNA and Colforsin results in increased expression of FGF2 protein CTD PMID:10320526 FGF2 Human copper atom multiple interactions EXP 6480464 [Chelating Agents binds to Copper] which affects the expression of FGF2 mRNA CTD PMID:30911355 FGF2 Human copper(0) multiple interactions EXP 6480464 [Chelating Agents binds to Copper] which affects the expression of FGF2 mRNA CTD PMID:30911355 FGF2 Human copper(II) chloride increases expression EXP 6480464 cupric chloride results in increased expression of FGF2 mRNA CTD PMID:38568856 FGF2 Human copper(II) sulfate multiple interactions ISO Fgf2 (Mus musculus) 6480464 Copper Sulfate inhibits the reaction [SLC31A1 gene mutant form inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein]] and Copper Sulfate inhibits the reaction [SLC31A1 gene mutant form inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK3 protein]] CTD PMID:22842628 FGF2 Human crocidolite asbestos increases expression EXP 6480464 Asbestos and Crocidolite results in increased expression of FGF2 mRNA CTD PMID:18687144 FGF2 Human crocidolite asbestos multiple interactions EXP 6480464 IL1RN protein promotes the reaction [Asbestos more ... CTD PMID:28056339 FGF2 Human crocidolite asbestos multiple interactions ISO Fgf2 (Mus musculus) 6480464 [CASP1 protein affects the susceptibility to Asbestos and Crocidolite] which affects the expression of FGF2 protein CTD PMID:28056339 FGF2 Human crocidolite asbestos increases secretion EXP 6480464 Asbestos and Crocidolite results in increased secretion of FGF2 protein CTD PMID:28056339 FGF2 Human crocidolite asbestos affects expression EXP 6480464 Asbestos and Crocidolite affects the expression of FGF2 mRNA CTD PMID:17331233 FGF2 Human Cuprizon increases expression ISO Fgf2 (Rattus norvegicus) 6480464 Cuprizone results in increased expression of FGF2 mRNA CTD PMID:27523638 FGF2 Human Cuprizon decreases expression ISO Fgf2 (Rattus norvegicus) 6480464 Cuprizone results in decreased expression of FGF2 mRNA CTD PMID:26577399 FGF2 Human curcumin decreases expression EXP 6480464 Curcumin results in decreased expression of FGF2 protein CTD PMID:23555722 FGF2 Human curcumin increases expression EXP 6480464 Curcumin results in increased expression of FGF2 protein CTD PMID:23555722 FGF2 Human cycloheximide multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 Cycloheximide inhibits the reaction [Dinoprost affects the localization of FGF2 protein] and Cycloheximide promotes the reaction [FGF2 protein results in increased expression of SERPINE1 mRNA] CTD PMID:15654655 and PMID:9798919 FGF2 Human cyclosporin A multiple interactions EXP 6480464 [Cyclosporine co-treated with Cholic Acids] affects the expression of FGF2 mRNA CTD PMID:27344345 FGF2 Human cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of FGF2 mRNA CTD PMID:27989131 and PMID:38447685 FGF2 Human D-glucose increases expression ISO Fgf2 (Rattus norvegicus) 6480464 Glucose results in increased expression of FGF2 mRNA and Glucose results in increased expression of FGF2 protein CTD PMID:1518840 and PMID:19759273 FGF2 Human D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of FGF2 mRNA CTD PMID:31655124 FGF2 Human D-glucose multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 Glucosamine promotes the reaction [Glucose results in increased expression of FGF2 mRNA] CTD PMID:1518840 FGF2 Human DDT decreases expression EXP 6480464 DDT results in decreased expression of FGF2 mRNA CTD PMID:31521043 FGF2 Human deguelin increases expression EXP 6480464 deguelin results in increased expression of FGF2 mRNA CTD PMID:33512557 FGF2 Human dermatan sulfate affects binding EXP 6480464 [Chondroitin Sulfates binds to Dermatan Sulfate] which binds to FGF2 protein CTD PMID:15385557 FGF2 Human dermatan sulfate increases activity ISO Fgf2 (Mus musculus) 6480464 Dermatan Sulfate analog results in increased activity of FGF2 protein CTD PMID:15563459 FGF2 Human dexamethasone multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 Dexamethasone inhibits the reaction [nitrofen results in decreased expression of FGF2 mRNA] CTD PMID:10646786 FGF2 Human dexamethasone multiple interactions ISO Fgf2 (Mus musculus) 6480464 [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FGF2 protein more ... CTD PMID:27568862 and PMID:28285642 FGF2 Human dextran sulfate multiple interactions ISO Fgf2 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FGF2 mRNA CTD PMID:29950665 FGF2 Human diallyl trisulfide increases expression EXP 6480464 diallyl trisulfide results in increased expression of FGF2 mRNA CTD PMID:34995734 FGF2 Human diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of FGF2 mRNA CTD PMID:22521957 FGF2 Human diarsenic trioxide multiple interactions EXP 6480464 Arsenic Trioxide inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein] and Arsenic Trioxide inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK3 protein] CTD PMID:15723287 FGF2 Human diazepam increases expression EXP 6480464 Diazepam results in increased expression of FGF2 mRNA CTD PMID:19114084 FGF2 Human diazinon decreases expression ISO Fgf2 (Rattus norvegicus) 6480464 Diazinon results in decreased expression of FGF2 mRNA CTD PMID:17589599 and PMID:19130878 FGF2 Human diazinon decreases expression ISO Fgf2 (Mus musculus) 6480464 Diazinon results in decreased expression of FGF2 mRNA CTD PMID:35934178 FGF2 Human diazinon affects expression ISO Fgf2 (Rattus norvegicus) 6480464 Diazinon affects the expression of FGF2 mRNA CTD PMID:22546817 FGF2 Human dibutyl phthalate multiple interactions ISO Fgf2 (Mus musculus) 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of FGF2 mRNA CTD PMID:37021957 FGF2 Human dichlorine multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 [Ozone co-treated with Chlorine] affects the expression of FGF2 mRNA CTD PMID:18636392 FGF2 Human dichlorine decreases expression ISO Fgf2 (Rattus norvegicus) 6480464 Chlorine results in decreased expression of FGF2 mRNA CTD PMID:18636392 FGF2 Human dieldrin decreases expression ISO Fgf2 (Rattus norvegicus) 6480464 Dieldrin results in decreased expression of FGF2 mRNA CTD PMID:19130878 FGF2 Human dieldrin affects expression ISO Fgf2 (Rattus norvegicus) 6480464 Dieldrin affects the expression of FGF2 mRNA CTD PMID:22546817 FGF2 Human diethyl phthalate multiple interactions ISO Fgf2 (Mus musculus) 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of FGF2 mRNA CTD PMID:37021957 FGF2 Human diethylstilbestrol decreases expression ISO Fgf2 (Rattus norvegicus) 6480464 Diethylstilbestrol results in decreased expression of FGF2 mRNA CTD PMID:17005392 FGF2 Human diisobutyl phthalate multiple interactions ISO Fgf2 (Mus musculus) 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of FGF2 mRNA CTD PMID:37021957 FGF2 Human diisononyl phthalate multiple interactions ISO Fgf2 (Mus musculus) 6480464 [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of FGF2 mRNA CTD PMID:37021957 FGF2 Human dimethylarsinic acid increases expression ISO Fgf2 (Mus musculus) 6480464 Cacodylic Acid results in increased expression of FGF2 mRNA CTD PMID:15345372 FGF2 Human dioxygen multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 Oxygen inhibits the reaction [Paraquat results in increased expression of FGF2 mRNA] CTD PMID:26722498 FGF2 Human dioxygen multiple interactions ISO Fgf2 (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FGF2 mRNA CTD PMID:30529165 FGF2 Human diprotium oxide increases expression EXP 6480464 Water results in increased expression of FGF2 mRNA CTD PMID:26800359 FGF2 Human divanadium pentaoxide decreases expression EXP 6480464 vanadium pentoxide results in decreased expression of FGF2 mRNA CTD PMID:17459161 FGF2 Human dizocilpine maleate increases expression ISO Fgf2 (Rattus norvegicus) 6480464 Dizocilpine Maleate results in increased expression of FGF2 mRNA CTD PMID:9832142 FGF2 Human dobutamine affects response to substance EXP 6480464 FGF2 protein affects the susceptibility to Dobutamine CTD PMID:14583313 FGF2 Human dobutamine affects response to substance ISO Fgf2 (Mus musculus) 6480464 FGF2 protein affects the susceptibility to Dobutamine CTD PMID:10491406 FGF2 Human dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGF2 mRNA CTD PMID:27188386 FGF2 Human doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of FGF2 mRNA CTD PMID:29803840 FGF2 Human entinostat increases expression EXP 6480464 entinostat results in increased expression of FGF2 mRNA CTD PMID:26272509 FGF2 Human entinostat multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGF2 mRNA CTD PMID:27188386 FGF2 Human Erionite increases expression ISO Fgf2 (Mus musculus) 6480464 erionite results in increased expression of FGF2 mRNA CTD PMID:29279043 FGF2 Human ethanol increases expression ISO Fgf2 (Mus musculus) 405855870 ethanol increases expression of FGF2 mRNA in dorsal striatum RGD FGF2 Human etoposide affects response to substance EXP 6480464 FGF2 protein affects the susceptibility to Etoposide CTD PMID:16217747 FGF2 Human famotidine multiple interactions EXP 6480464 [Famotidine co-treated with Sucralfate] results in increased expression of FGF2 mRNA CTD PMID:17717918 FGF2 Human fenoldopam increases expression ISO Fgf2 (Rattus norvegicus) 6480464 Fenoldopam results in increased expression of FGF2 protein CTD PMID:12180796 FGF2 Human fenpyroximate increases expression EXP 6480464 fenpyroximate results in increased expression of FGF2 mRNA CTD PMID:33512557 FGF2 Human finasteride multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 Finasteride inhibits the reaction [Testosterone results in increased expression of FGF2 protein] CTD PMID:27866977 FGF2 Human fluoranthene multiple interactions ISO Fgf2 (Mus musculus) 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of FGF2 mRNA CTD PMID:28329830 FGF2 Human fluoxetine multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 [Fluoxetine co-treated with olanzapine] results in increased expression of FGF2 mRNA CTD PMID:15158429 FGF2 Human flutamide multiple interactions EXP 6480464 Flutamide inhibits the reaction [Dihydrotestosterone results in increased expression of FGF2 mRNA] and Flutamide inhibits the reaction [Dihydrotestosterone results in increased expression of FGF2 protein] CTD PMID:20421132 FGF2 Human flutamide increases expression ISO Fgf2 (Rattus norvegicus) 6480464 Flutamide results in increased expression of FGF2 mRNA CTD PMID:24793618 FGF2 Human folic acid increases expression ISO Fgf2 (Mus musculus) 6480464 Folic Acid results in increased expression of FGF2 mRNA CTD PMID:25629700 FGF2 Human formoterol fumarate multiple interactions EXP 6480464 [Beclomethasone co-treated with Formoterol Fumarate] inhibits the reaction [FGF2 protein results in increased secretion of FN1 protein] more ... CTD PMID:18076728 FGF2 Human fulvestrant multiple interactions EXP 6480464 [bisphenol S co-treated with Fulvestrant] results in increased methylation of FGF2 gene and Fulvestrant inhibits the reaction [FGF2 protein results in increased expression of CCND1 protein] CTD PMID:20179196 and PMID:31601247 FGF2 Human fulvestrant multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 fulvestrant inhibits the reaction [naringin results in increased expression of FGF2 mRNA] CTD PMID:23596885 FGF2 Human furan decreases methylation ISO Fgf2 (Rattus norvegicus) 6480464 furan results in decreased methylation of FGF2 gene CTD PMID:27387713 FGF2 Human furan increases expression ISO Fgf2 (Rattus norvegicus) 6480464 furan results in increased expression of FGF2 mRNA CTD PMID:27387713 FGF2 Human furosemide decreases expression ISO Fgf2 (Rattus norvegicus) 6480464 Furosemide results in decreased expression of FGF2 mRNA CTD PMID:16526316 FGF2 Human galactose increases expression ISO Fgf2 (Rattus norvegicus) 6480464 Galactose results in increased expression of FGF2 protein CTD PMID:30367734 FGF2 Human galactose multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 Alpinia oxyphylla fruit extract inhibits the reaction [Galactose results in increased expression of FGF2 protein] CTD PMID:30367734 FGF2 Human gamma-tocopherol decreases expression EXP 6480464 Tocopherols results in decreased expression of FGF2 mRNA CTD PMID:15878867 FGF2 Human gemcitabine multiple interactions EXP 6480464 [Gemcitabine co-treated with IFNA2 protein] results in increased expression of FGF2 protein CTD PMID:12738744 FGF2 Human gemcitabine increases expression EXP 6480464 Gemcitabine results in increased expression of FGF2 protein CTD PMID:20531411 FGF2 Human genistein multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 [Genistein co-treated with Methoxychlor] results in decreased expression of FGF2 mRNA CTD PMID:21782745 FGF2 Human genistein increases expression ISO Fgf2 (Mus musculus) 6480464 Genistein results in increased expression of FGF2 mRNA CTD PMID:32186404 FGF2 Human glucose increases expression ISO Fgf2 (Rattus norvegicus) 6480464 Glucose results in increased expression of FGF2 mRNA and Glucose results in increased expression of FGF2 protein CTD PMID:1518840 and PMID:19759273 FGF2 Human glucose decreases expression EXP 6480464 Glucose results in decreased expression of FGF2 mRNA CTD PMID:31655124 FGF2 Human glucose multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 Glucosamine promotes the reaction [Glucose results in increased expression of FGF2 mRNA] CTD PMID:1518840 FGF2 Human glycidol increases methylation ISO Fgf2 (Rattus norvegicus) 6480464 glycidol results in increased methylation of FGF2 promoter CTD PMID:33150595 FGF2 Human glycidol decreases expression ISO Fgf2 (Rattus norvegicus) 6480464 glycidol results in decreased expression of FGF2 mRNA CTD PMID:33150645 FGF2 Human gossypol decreases expression EXP 6480464 Gossypol results in decreased expression of FGF2 mRNA CTD PMID:19825521 FGF2 Human gossypol multiple interactions EXP 6480464 zoledronic acid promotes the reaction [Gossypol results in decreased expression of FGF2 mRNA] CTD PMID:19825521 FGF2 Human haloperidol multiple interactions ISO Fgf2 (Mus musculus) 405855870 haloperidol inhibits the reaction [ethanol increases expression of FGF2 mRNA in dorsal striatum] RGD FGF2 Human heparan sulfate multiple interactions EXP 6480464 Heparitin Sulfate binds to and affects the activity of FGF2 protein CTD PMID:15958608 FGF2 Human heparan sulfate affects binding ISO Fgf2 (Mus musculus) 6480464 Heparitin Sulfate binds to FGF2 protein CTD PMID:15464572 FGF2 Human heparan sulfate increases activity ISO Fgf2 (Mus musculus) 6480464 Heparitin Sulfate analog results in increased activity of FGF2 protein CTD PMID:12460940 FGF2 Human heparin affects binding EXP 6480464 Heparin binds to FGF2 protein and Heparin binds to FGFR1 protein binds to FGF2 protein CTD PMID:15096041 and PMID:17524524 FGF2 Human heparin decreases expression ISO Fgf2 (Rattus norvegicus) 6480464 Heparin results in decreased expression of FGF2 protein CTD PMID:8441232 FGF2 Human heparin affects binding ISO Fgf2 (Rattus norvegicus) 6480464 [Heparin binds to FGFR2 protein alternative form] which binds to FGF2 protein CTD PMID:10860838 FGF2 Human heparin multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 Heparin affects the reaction [FGF2 protein binds to FGFR4 protein] more ... CTD PMID:10336501 and PMID:14966081 FGF2 Human heparin affects activity ISO Fgf2 (Rattus norvegicus) 6480464 Heparin affects the activity of FGF2 protein CTD PMID:15232299 FGF2 Human heparin multiple interactions ISO Fgf2 (Mus musculus) 6480464 Heparin promotes the reaction [FGFR1 protein binds to FGF2 protein] and Heparin promotes the reaction [FGFR2 protein binds to FGF2 protein] CTD PMID:1373495 and PMID:1379594 FGF2 Human hexadecanoic acid multiple interactions EXP 6480464 [osteum co-treated with Palmitic Acid] results in increased expression of FGF2 mRNA and MRI-1867 inhibits the reaction [[osteum co-treated with Palmitic Acid] results in increased expression of FGF2 mRNA] CTD PMID:31454063 FGF2 Human Hexadimethrine bromide decreases response to substance EXP 6480464 Hexadimethrine Bromide results in decreased susceptibility to FGF2 protein CTD PMID:21887340 FGF2 Human hydrogen chloride decreases expression EXP 6480464 Hydrochloric Acid results in decreased expression of FGF2 mRNA CTD PMID:15046208 FGF2 Human hydrogen peroxide multiple interactions EXP 6480464 Hydrogen Peroxide promotes the reaction [FGF2 protein binds to FGFR1 protein] CTD PMID:8849686 FGF2 Human hydrogen peroxide multiple interactions ISO Fgf2 (Mus musculus) 6480464 Hydrogen Peroxide inhibits the reaction [SLC31A1 gene mutant form inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein]] and Hydrogen Peroxide inhibits the reaction [SLC31A1 gene mutant form inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK3 protein]] CTD PMID:22842628 FGF2 Human iloprost increases expression EXP 6480464 Iloprost results in increased expression of FGF2 mRNA CTD PMID:16373414 FGF2 Human iloprost multiple interactions EXP 6480464 RTKI cpd inhibits the reaction [Iloprost results in increased expression of FGF2 mRNA] CTD PMID:16373414 FGF2 Human imiquimod decreases expression EXP 6480464 imiquimod results in decreased expression of FGF2 CTD PMID:16368197 FGF2 Human indole-3-methanol affects expression ISO Fgf2 (Rattus norvegicus) 6480464 indole-3-carbinol affects the expression of FGF2 mRNA CTD PMID:21396975 FGF2 Human indometacin multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 Indomethacin inhibits the reaction [FGF2 protein results in increased expression of CCND1 protein] more ... CTD PMID:11170841 FGF2 Human indometacin increases expression ISO Fgf2 (Rattus norvegicus) 6480464 Indomethacin results in increased expression of FGF2 mRNA CTD PMID:17440234 FGF2 Human irinotecan increases expression EXP 6480464 Irinotecan metabolite results in increased expression of FGF2 mRNA and Irinotecan results in increased expression of FGF2 mRNA CTD PMID:15956246 FGF2 Human Isradipine increases secretion EXP 6480464 Isradipine results in increased secretion of FGF2 protein CTD PMID:15257873 FGF2 Human kaempferol multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 [kaempferol inhibits the reaction [Lipopolysaccharides co-treated with TNF protein]] which results in increased expression of FGF2 protein CTD PMID:36049518 FGF2 Human kainic acid increases expression ISO Fgf2 (Rattus norvegicus) 6480464 Kainic Acid results in increased expression of FGF2 mRNA CTD PMID:7649223 FGF2 Human lansoprazole decreases expression EXP 6480464 Lansoprazole results in decreased expression of FGF2 protein CTD PMID:9881512 FGF2 Human Lasiocarpine decreases expression EXP 6480464 lasiocarpine metabolite results in decreased expression of FGF2 mRNA CTD PMID:30465738 FGF2 Human lead diacetate decreases expression ISO Fgf2 (Rattus norvegicus) 6480464 lead acetate results in decreased expression of FGF2 mRNA CTD PMID:22160880 FGF2 Human lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of FGF2 mRNA CTD PMID:38568856 FGF2 Human lead(0) increases expression EXP 6480464 Lead results in increased expression of FGF2 CTD PMID:28395533 FGF2 Human leflunomide increases expression ISO Fgf2 (Mus musculus) 6480464 leflunomide results in increased expression of FGF2 mRNA CTD PMID:19751817 FGF2 Human leukotriene B4 increases expression ISO Fgf2 (Mus musculus) 6480464 Leukotriene B4 results in increased expression of FGF2 mRNA CTD PMID:30818366 FGF2 Human lipopolysaccharide multiple interactions ISO Fgf2 (Mus musculus) 6480464 coagulin-L inhibits the reaction [Lipopolysaccharides results in increased expression of FGF2 protein] and Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of FGF2 protein] CTD PMID:27568862 FGF2 Human lipopolysaccharide increases expression ISO Fgf2 (Rattus norvegicus) 6480464 Lipopolysaccharides results in increased expression of FGF2 protein CTD PMID:27098997 and PMID:30980805 FGF2 Human lipopolysaccharide multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 [kaempferol inhibits the reaction [Lipopolysaccharides co-treated with TNF protein]] which results in increased expression of FGF2 protein more ... CTD PMID:27098997 more ... FGF2 Human lipopolysaccharide multiple interactions EXP 6480464 2'-hydroxyflavanone inhibits the reaction [Lipopolysaccharides results in increased secretion of FGF2 protein] and valdecoxib affects the reaction [Lipopolysaccharides results in increased secretion of FGF2 protein] CTD PMID:24431307 and PMID:32800949 FGF2 Human lipopolysaccharide increases secretion EXP 6480464 Lipopolysaccharides results in increased secretion of FGF2 protein CTD PMID:24431307 and PMID:32800949 FGF2 Human lipopolysaccharide increases expression ISO Fgf2 (Mus musculus) 6480464 Lipopolysaccharides results in increased expression of FGF2 protein CTD PMID:27568862 FGF2 Human luteolin multiple interactions EXP 6480464 Luteolin inhibits the reaction [Sodium Chloride results in increased expression of FGF2 mRNA] CTD PMID:26800359 FGF2 Human LY294002 multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [FGF2 protein results in increased expression of and results in increased activity of HIF1A protein] more ... CTD PMID:15631803 and PMID:26800359 FGF2 Human LY294002 decreases expression ISO Fgf2 (Mus musculus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of FGF2 protein CTD PMID:29129800 FGF2 Human LY294002 multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [FGF2 protein results in increased expression of UCP1 mRNA] CTD PMID:11742803 FGF2 Human manganese(II) chloride decreases expression ISO Fgf2 (Mus musculus) 6480464 manganese chloride results in decreased expression of FGF2 mRNA CTD PMID:28801915 FGF2 Human manganese(II) chloride increases methylation ISO Fgf2 (Rattus norvegicus) 6480464 manganese chloride results in increased methylation of FGF2 gene CTD PMID:28801915 FGF2 Human Mecamylamine multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 Mecamylamine inhibits the reaction [Nicotine results in increased expression of FGF2 mRNA] CTD PMID:9832142 FGF2 Human melittin decreases expression EXP 6480464 Melitten results in decreased expression of FGF2 mRNA CTD PMID:18076793 FGF2 Human mercury atom increases expression EXP 6480464 Mercury results in increased expression of FGF2 mRNA CTD PMID:16823088 FGF2 Human mercury(0) increases expression EXP 6480464 Mercury results in increased expression of FGF2 mRNA CTD PMID:16823088 FGF2 Human methamphetamine increases expression ISO Fgf2 (Rattus norvegicus) 6480464 Methamphetamine results in increased expression of FGF2 mRNA CTD PMID:19564919 FGF2 Human methoxychlor multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 [Genistein co-treated with Methoxychlor] results in decreased expression of FGF2 mRNA CTD PMID:21782745 FGF2 Human methylarsonic acid increases expression ISO Fgf2 (Mus musculus) 6480464 monomethylarsonic acid results in increased expression of FGF2 mRNA CTD PMID:15345372 FGF2 Human methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of FGF2 mRNA CTD PMID:23179753 and PMID:28001369 FGF2 Human methylmercury chloride increases expression ISO Fgf2 (Rattus norvegicus) 6480464 methylmercuric chloride results in increased expression of FGF2 mRNA CTD PMID:31378766 FGF2 Human methylseleninic acid decreases expression EXP 6480464 methylselenic acid results in decreased expression of FGF2 mRNA CTD PMID:12517777 FGF2 Human mitomycin C increases expression EXP 6480464 Mitomycin results in increased expression of FGF2 protein CTD PMID:16585851 FGF2 Human MK-2206 multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 [MK 2206 inhibits the reaction [Lipopolysaccharides co-treated with TNF protein]] which results in increased expression of FGF2 protein CTD PMID:36049518 FGF2 Human monosodium L-glutamate multiple interactions ISO Fgf2 (Mus musculus) 6480464 [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of FGF2 mRNA CTD PMID:19001666 FGF2 Human morphine decreases secretion EXP 6480464 Morphine results in decreased secretion of FGF2 protein CTD PMID:20564181 FGF2 Human morphine multiple interactions EXP 6480464 Naloxone inhibits the reaction [Morphine results in decreased secretion of FGF2 protein] and OPRM1 protein affects the reaction [Morphine results in decreased secretion of FGF2 protein] CTD PMID:20564181 FGF2 Human Morroniside increases expression ISO Fgf2 (Rattus norvegicus) 6480464 morroniside results in increased expression of FGF2 protein CTD PMID:24979385 FGF2 Human N,N-diethyl-m-toluamide multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 [Permethrin co-treated with DEET] results in decreased methylation of FGF2 gene and [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of and results in increased secretion of FGF2 protein CTD PMID:28659758 and PMID:33148267 FGF2 Human N-acetyl-L-cysteine decreases expression EXP 6480464 Acetylcysteine results in decreased expression of FGF2 mRNA CTD PMID:16084531 FGF2 Human N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [hydroxyethyl methacrylate results in increased secretion of FGF2 protein] CTD PMID:19176594 FGF2 Human N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of FGF2 mRNA CTD PMID:25234470 FGF2 Human N-methyl-4-phenylpyridinium increases methylation ISO Fgf2 (Rattus norvegicus) 6480464 1-Methyl-4-phenylpyridinium results in increased methylation of FGF2 gene CTD PMID:28801915 FGF2 Human N-nitrosodiethylamine increases expression ISO Fgf2 (Rattus norvegicus) 6480464 Diethylnitrosamine results in increased expression of FGF2 protein CTD PMID:24632418 FGF2 Human naloxone multiple interactions EXP 6480464 Naloxone inhibits the reaction [Morphine results in decreased secretion of FGF2 protein] CTD PMID:20564181 FGF2 Human naringin multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 fulvestrant inhibits the reaction [naringin results in increased expression of FGF2 mRNA] CTD PMID:23596885 FGF2 Human naringin increases expression ISO Fgf2 (Rattus norvegicus) 6480464 naringin results in increased expression of FGF2 mRNA CTD PMID:23596885 FGF2 Human nickel atom decreases expression ISO Fgf2 (Rattus norvegicus) 6480464 Nickel results in decreased expression of FGF2 mRNA CTD PMID:19130878 FGF2 Human nickel dichloride affects expression ISO Fgf2 (Rattus norvegicus) 6480464 nickel chloride affects the expression of FGF2 mRNA CTD PMID:22546817 FGF2 Human nickel sulfate increases expression EXP 6480464 nickel sulfate results in increased expression of FGF2 mRNA CTD PMID:22714537 FGF2 Human nicotine increases expression ISO Fgf2 (Rattus norvegicus) 6480464 Nicotine results in increased expression of FGF2 mRNA and Nicotine results in increased expression of FGF2 protein CTD PMID:15465631 more ... FGF2 Human nicotine increases expression ISO Fgf2 (Mus musculus) 6480464 Nicotine results in increased expression of FGF2 mRNA and Nicotine results in increased expression of FGF2 protein CTD PMID:31622651 and PMID:32512034 FGF2 Human nicotine increases secretion EXP 6480464 Nicotine results in increased secretion of FGF2 protein CTD PMID:16365874 and PMID:22198237 FGF2 Human nicotine multiple interactions EXP 6480464 [triethyl-(beta-4-stilbenoxyethyl)ammonium inhibits the reaction [Nicotine promotes the reaction [EGR1 protein binds to FGF2 promoter]]] which results in decreased expression of FGF2 mRNA more ... CTD PMID:22198237 FGF2 Human nicotine multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 Mecamylamine inhibits the reaction [Nicotine results in increased expression of FGF2 mRNA] and triethyl-(beta-4-stilbenoxyethyl)ammonium inhibits the reaction [Nicotine results in increased expression of FGF2 mRNA] CTD PMID:22198237 and PMID:9832142 FGF2 Human nicotine decreases expression ISO Fgf2 (Rattus norvegicus) 6480464 Nicotine results in decreased expression of FGF2 protein CTD PMID:14732461 FGF2 Human nifedipine affects response to substance EXP 6480464 Nifedipine affects the susceptibility to FGF2 protein CTD PMID:15141722 FGF2 Human nifedipine multiple interactions EXP 6480464 Nifedipine inhibits the reaction [FGF2 protein results in increased expression of FOS mRNA] CTD PMID:16188231 FGF2 Human nitrofen multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 Dexamethasone inhibits the reaction [nitrofen results in decreased expression of FGF2 mRNA] CTD PMID:10646786 FGF2 Human nitrofen decreases expression ISO Fgf2 (Rattus norvegicus) 6480464 nitrofen results in decreased expression of FGF2 mRNA CTD PMID:10646786 and PMID:10898222 FGF2 Human nitroprusside multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 FGF2 protein inhibits the reaction [Nitroprusside results in decreased expression of BCL2 protein] and FGF2 protein inhibits the reaction [Nitroprusside results in increased expression of BAX protein] CTD PMID:10203697 FGF2 Human nitroprusside decreases response to substance EXP 6480464 FGF2 protein results in decreased susceptibility to Nitroprusside CTD PMID:10203697 FGF2 Human O-(chloroacetylcarbamoyl)fumagillol multiple interactions EXP 6480464 [O-(chloroacetylcarbamoyl)fumagillol co-treated with docetaxel] results in decreased expression of FGF2 protein CTD PMID:12576464 FGF2 Human O-(chloroacetylcarbamoyl)fumagillol decreases expression EXP 6480464 O-(chloroacetylcarbamoyl)fumagillol results in decreased expression of FGF2 protein CTD PMID:12576464 FGF2 Human olanzapine multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 [Fluoxetine co-treated with olanzapine] results in increased expression of FGF2 mRNA CTD PMID:15158429 FGF2 Human Oxadiazon multiple interactions EXP 6480464 ACYP2 protein affects the reaction [oxadiazon inhibits the reaction [FGF2 protein results in increased expression of GAP43 protein]] and oxadiazon inhibits the reaction [FGF2 protein results in increased expression of GAP43 protein] CTD PMID:30391265 FGF2 Human oxilofrine multiple interactions EXP 6480464 oxilofrine inhibits the reaction [VEGFA protein results in increased expression of FGF2 protein] CTD PMID:20643105 FGF2 Human oxybenzone increases expression EXP 6480464 oxybenzone results in increased expression of FGF2 mRNA CTD PMID:36581016 FGF2 Human ozone multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 [Ozone co-treated with Chlorine] affects the expression of FGF2 mRNA CTD PMID:18636392 FGF2 Human ozone multiple interactions ISO Fgf2 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of Ozone] which results in increased expression of FGF2 mRNA CTD PMID:27106289 FGF2 Human ozone multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of FGF2 mRNA more ... CTD PMID:32699268 FGF2 Human paclitaxel decreases response to substance EXP 6480464 FGF2 protein results in decreased susceptibility to Paclitaxel CTD PMID:16741658 FGF2 Human paracetamol increases expression ISO Fgf2 (Mus musculus) 6480464 Acetaminophen results in increased expression of FGF2 mRNA CTD PMID:21135413 FGF2 Human paracetamol decreases expression ISO Fgf2 (Rattus norvegicus) 6480464 Acetaminophen results in decreased expression of FGF2 mRNA CTD PMID:33387578 FGF2 Human paracetamol increases activity ISO Fgf2 (Rattus norvegicus) 6480464 Acetaminophen results in increased activity of FGF2 protein CTD PMID:25858767 FGF2 Human paracetamol multiple interactions ISO Fgf2 (Mus musculus) 6480464 FLT1 protein affects the reaction [Acetaminophen results in increased expression of FGF2 mRNA] CTD PMID:21135413 FGF2 Human paraquat increases expression ISO Fgf2 (Rattus norvegicus) 6480464 Paraquat results in increased expression of FGF2 mRNA and Paraquat results in increased expression of FGF2 protein CTD PMID:18198484 more ... FGF2 Human paraquat decreases secretion EXP 6480464 Paraquat results in decreased secretion of FGF2 protein CTD PMID:30698896 FGF2 Human paraquat multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 HDAC6 protein inhibits the reaction [Thalidomide inhibits the reaction [Paraquat results in increased expression of FGF2 protein]] more ... CTD PMID:26722498 and PMID:33015978 FGF2 Human parthenolide multiple interactions EXP 6480464 parthenolide inhibits the reaction [FGF2 protein results in increased activity of [NFKB1 protein binds to RELA protein]] more ... CTD PMID:16921510 FGF2 Human permethrin multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 [Permethrin co-treated with DEET] results in decreased methylation of FGF2 gene and [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of and results in increased secretion of FGF2 protein CTD PMID:28659758 and PMID:33148267 FGF2 Human phenylephrine multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 Phenylephrine promotes the reaction [EGR1 protein binds to FGF2 promoter] CTD PMID:10779383 FGF2 Human phorbol 13-acetate 12-myristate multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 Tetradecanoylphorbol Acetate inhibits the reaction [Dinoprost affects the localization of FGF2 protein] and Tetradecanoylphorbol Acetate promotes the reaction [EGR1 protein binds to FGF2 promoter] CTD PMID:10779383 and PMID:15654655 FGF2 Human phorbol 13-acetate 12-myristate increases secretion EXP 6480464 Tetradecanoylphorbol Acetate results in increased secretion of FGF2 protein CTD PMID:11874475 FGF2 Human piroxicam multiple interactions EXP 6480464 Cisplatin affects the reaction [Piroxicam results in decreased expression of FGF2 mRNA] CTD PMID:21858171 FGF2 Human piroxicam decreases expression EXP 6480464 Piroxicam results in decreased expression of FGF2 mRNA CTD PMID:21858171 FGF2 Human platycodin D decreases expression ISO Fgf2 (Rattus norvegicus) 6480464 platycodin D results in decreased expression of FGF2 protein CTD PMID:29595072 FGF2 Human potassium chromate decreases expression EXP 6480464 potassium chromate(VI) results in decreased expression of FGF2 mRNA CTD PMID:22079256 FGF2 Human potassium chromate multiple interactions EXP 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FGF2 mRNA CTD PMID:22079256 FGF2 Human potassium dichromate decreases expression EXP 6480464 Potassium Dichromate results in decreased expression of FGF2 protein CTD PMID:23718831 FGF2 Human progesterone multiple interactions EXP 6480464 [Progesterone co-treated with Estradiol] results in increased expression of FGF2 mRNA CTD PMID:18692832 FGF2 Human prostaglandin F2alpha multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Dinoprost affects the localization of FGF2 protein] more ... CTD PMID:15654655 and PMID:16365892 FGF2 Human prostaglandin F2alpha affects localization ISO Fgf2 (Rattus norvegicus) 6480464 Dinoprost affects the localization of FGF2 protein CTD PMID:15654655 FGF2 Human Pyridostigmine bromide multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of and results in increased secretion of FGF2 protein CTD PMID:28659758 FGF2 Human quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Sodium Chloride results in increased expression of FGF2 mRNA] CTD PMID:26800359 FGF2 Human resveratrol decreases activity ISO Fgf2 (Mus musculus) 6480464 resveratrol results in decreased activity of FGF2 protein CTD PMID:16675471 FGF2 Human resveratrol decreases expression ISO Fgf2 (Mus musculus) 6480464 resveratrol results in decreased expression of FGF2 mRNA CTD PMID:25338179 FGF2 Human resveratrol multiple interactions ISO Fgf2 (Mus musculus) 6480464 resveratrol inhibits the reaction [FGF2 protein results in increased expression of TNFRSF11B mRNA] more ... CTD PMID:25290095 FGF2 Human resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of FGF2 mRNA and resveratrol results in decreased expression of FGF2 protein CTD PMID:17935668 and PMID:20028382 FGF2 Human rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of FGF2 mRNA CTD PMID:29955902 and PMID:37394047 FGF2 Human rotenone increases expression ISO Fgf2 (Mus musculus) 6480464 Rotenone results in increased expression of FGF2 mRNA and Rotenone results in increased expression of FGF2 protein CTD PMID:34045544 FGF2 Human rottlerin multiple interactions ISO Fgf2 (Mus musculus) 6480464 rottlerin inhibits the reaction [FGF2 protein results in increased activity of RUNX2 protein] and rottlerin inhibits the reaction [FGF2 protein results in increased expression of RUNX2 mRNA] CTD PMID:12403780 FGF2 Human Rutecarpine increases expression EXP 6480464 rutecarpine results in increased expression of FGF2 mRNA CTD PMID:34955744 FGF2 Human S-nitroso-N-acetyl-D-penicillamine multiple interactions EXP 6480464 S-Nitroso-N-Acetylpenicillamine promotes the reaction [FGF2 protein results in increased expression of TP53 protein] CTD PMID:16351512 FGF2 Human SB 203580 multiple interactions EXP 6480464 SB 203580 inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK14 protein] more ... CTD PMID:15249425 more ... FGF2 Human SB 203580 increases secretion ISO Fgf2 (Rattus norvegicus) 6480464 SB 203580 results in increased secretion of FGF2 protein CTD PMID:28087833 FGF2 Human SB 203580 multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 SB 203580 inhibits the reaction [AGT protein modified form results in increased expression of FGF2 mRNA] more ... CTD PMID:21108934 and PMID:28087833 FGF2 Human SB 203580 multiple interactions ISO Fgf2 (Mus musculus) 6480464 SB 203580 inhibits the reaction [FGF2 protein results in increased secretion of TNFRSF11B protein] CTD PMID:25290095 FGF2 Human SB 203580 decreases activity EXP 6480464 SB 203580 results in decreased activity of FGF2 protein CTD PMID:15249425 FGF2 Human SB 431542 multiple interactions EXP 6480464 4-(5-benzo(1 more ... CTD PMID:26800359 more ... FGF2 Human SCH772984 increases secretion ISO Fgf2 (Rattus norvegicus) 6480464 SCH772984 results in increased secretion of FGF2 protein CTD PMID:28087833 FGF2 Human SCH772984 multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 SCH772984 promotes the reaction [diphenylarsinic acid results in increased secretion of FGF2 protein] CTD PMID:28087833 FGF2 Human scutellarin decreases expression ISO Fgf2 (Rattus norvegicus) 6480464 scutellarin results in decreased expression of FGF2 protein CTD PMID:16297343 FGF2 Human serpentine asbestos increases secretion EXP 6480464 [Asbestos and Serpentine results in increased secretion of IL1B protein] which results in increased secretion of FGF2 protein CTD PMID:23017228 FGF2 Human serpentine asbestos increases expression ISO Fgf2 (Rattus norvegicus) 6480464 Asbestos and Serpentine results in increased expression of FGF2 mRNA CTD PMID:9400719 FGF2 Human silibinin multiple interactions ISO Fgf2 (Mus musculus) 6480464 Silybin inhibits the reaction [Urethane results in increased secretion of FGF2 protein] CTD PMID:16788158 FGF2 Human silicon dioxide increases secretion EXP 6480464 Silicon Dioxide results in increased secretion of FGF2 protein CTD PMID:22300531 and PMID:25351596 FGF2 Human silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of FGF2 mRNA CTD PMID:25351596 FGF2 Human silver atom increases expression EXP 6480464 Silver results in increased expression of FGF2 mRNA CTD PMID:26551752 FGF2 Human silver(0) increases expression EXP 6480464 Silver results in increased expression of FGF2 mRNA CTD PMID:26551752 FGF2 Human simvastatin increases expression EXP 6480464 Simvastatin results in increased expression of FGF2 CTD PMID:20381859 FGF2 Human sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of FGF2 mRNA CTD PMID:12703962 and PMID:38568856 FGF2 Human sodium arsenite increases expression ISO Fgf2 (Mus musculus) 6480464 sodium arsenite results in increased expression of FGF2 mRNA CTD PMID:28370166 FGF2 Human sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of FGF2 mRNA CTD PMID:19615344 and PMID:34032870 FGF2 Human sodium chloride increases expression EXP 6480464 Sodium Chloride results in increased expression of FGF2 mRNA CTD PMID:26800359 FGF2 Human sodium chloride increases secretion EXP 6480464 Sodium Chloride results in increased secretion of FGF2 protein CTD PMID:26800359 FGF2 Human sodium chloride multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Sodium Chloride results in increased expression of FGF2 mRNA] more ... CTD PMID:26800359 FGF2 Human Sodium oleate multiple interactions EXP 6480464 [osteum co-treated with Palmitic Acid] results in increased expression of FGF2 mRNA and MRI-1867 inhibits the reaction [[osteum co-treated with Palmitic Acid] results in increased expression of FGF2 mRNA] CTD PMID:31454063 FGF2 Human Soman increases expression ISO Fgf2 (Rattus norvegicus) 6480464 Soman results in increased expression of FGF2 mRNA CTD PMID:19281266 FGF2 Human Sucralfate multiple interactions EXP 6480464 [Famotidine co-treated with Sucralfate] results in increased expression of FGF2 mRNA CTD PMID:17717918 FGF2 Human sucrose increases expression EXP 6480464 Sucrose results in increased expression of FGF2 mRNA CTD PMID:26800359 FGF2 Human suramin increases expression EXP 6480464 Suramin results in increased expression of FGF2 CTD PMID:8394679 FGF2 Human Swertiamarin multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 swertiamarin inhibits the reaction [Testosterone results in increased expression of FGF2 protein] CTD PMID:27866977 FGF2 Human tamoxifen decreases response to substance EXP 6480464 FGF2 protein results in decreased susceptibility to Tamoxifen CTD PMID:20179196 FGF2 Human tamoxifen multiple interactions EXP 6480464 Tamoxifen inhibits the reaction [FGF2 protein results in increased expression of CCND1 protein] CTD PMID:20179196 FGF2 Human temozolomide multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 [temozolomide co-treated with Thalidomide] results in decreased expression of FGF2 protein CTD PMID:16327979 FGF2 Human temozolomide increases expression EXP 6480464 Temozolomide results in increased expression of FGF2 mRNA CTD PMID:31758290 FGF2 Human teniposide decreases response to substance EXP 6480464 FGF2 protein results in decreased susceptibility to Teniposide CTD PMID:20221717 FGF2 Human testosterone multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 Finasteride inhibits the reaction [Testosterone results in increased expression of FGF2 protein] more ... CTD PMID:27866977 FGF2 Human testosterone increases expression ISO Fgf2 (Rattus norvegicus) 6480464 Testosterone results in increased expression of FGF2 protein CTD PMID:27866977 FGF2 Human tetrachloromethane affects response to substance ISO Fgf2 (Mus musculus) 6480464 FGF2 protein affects the susceptibility to Carbon Tetrachloride CTD PMID:14507672 FGF2 Human tetrachloromethane increases expression ISO Fgf2 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in increased expression of FGF2 mRNA and Carbon Tetrachloride results in increased expression of FGF2 protein CTD PMID:16116963 and PMID:17158861 FGF2 Human tetrathiomolybdate(2-) multiple interactions EXP 6480464 [tetrathiomolybdate results in decreased activity of SOD1 protein] inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein] more ... CTD PMID:18480265 FGF2 Human thalidomide increases response to substance EXP 6480464 FGF2 protein results in increased susceptibility to Thalidomide CTD PMID:11555579 FGF2 Human thalidomide decreases expression EXP 6480464 Thalidomide results in decreased expression of FGF2 protein CTD PMID:12644816 and PMID:15863203 FGF2 Human thalidomide multiple interactions ISO Fgf2 (Rattus norvegicus) 6480464 [Temozolomide co-treated with Thalidomide] results in decreased expression of FGF2 protein more ... CTD PMID:16327979 and PMID:33015978 FGF2 Human thalidomide decreases activity EXP 6480464 Thalidomide results in decreased activity of FGF2 protein CTD PMID:17557286 FGF2 Human thalidomide multiple interactions EXP 6480464 Thalidomide promotes the reaction [FGF2 protein results in decreased expression of MMP2 protein] CTD PMID:14558594 FGF2 Human thalidomide affects secretion EXP 6480464 Thalidomide affects the secretion of FGF2 protein CTD PMID:15939924 FGF2 Human thalidomide affects expression EXP 6480464 Thalidomide affects the expression of FGF2 mRNA and Thalidomide affects the expression of FGF2 protein CTD PMID:15939924 FGF2 Human thyroxine increases expression ISO Fgf2 (Mus musculus) 6480464 Thyroxine results in increased expression of FGF2 mRNA CTD PMID:23935926 FGF2 Human titanium dioxide multiple interactions ISO Fgf2 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FGF2 mRNA CTD PMID:29950665 FGF2 Human titanium dioxide increases expression ISO Fgf2 (Mus musculus) 6480464 titanium dioxide results in increased expression of FGF2 mRNA CTD PMID:35295148 FGF2 Human tocopherol decreases expression EXP 6480464 Tocopherols results in decreased expression of FGF2 mRNA CTD PMID:15878867 FGF2 Human topotecan affects response to substance EXP 6480464 FGF2 protein affects the susceptibility to Topotecan CTD PMID:16217747 FGF2 Human trichloroethene increases expression ISO Fgf2 (Rattus norvegicus) 6480464 Trichloroethylene results in increased expression of FGF2 mRNA CTD PMID:33387578 FGF2 Human trichostatin A increases expression ISO Fgf2 (Mus musculus) 6480464 trichostatin A results in increased expression of FGF2 mRNA CTD PMID:23463510 FGF2 Human trichostatin A decreases expression EXP 6480464 trichostatin A results in decreased expression of FGF2 mRNA CTD PMID:24935251 FGF2 Human trifluoroacetic acid multiple interactions EXP 6480464 Acrylamide analog inhibits the reaction [Trifluoroacetic Acid results in increased degradation of FGF2 protein] CTD PMID:14733594 FGF2 Human triphenylstannane decreases expression ISO Fgf2 (Rattus norvegicus) 6480464 triphenyltin results in decreased expression of FGF2 mRNA CTD PMID:35489455 FGF2 Human triphenylstannane decreases expression ISO Fgf2 (Mus musculus) 6480464 triphenyltin results in decreased expression of FGF2 mRNA CTD PMID:35489455 FGF2 Human tyrphostin AG 1478 multiple interactions EXP 6480464 RTKI cpd inhibits the reaction [Iloprost results in increased expression of FGF2 mRNA] CTD PMID:16373414 FGF2 Human urethane multiple interactions ISO Fgf2 (Mus musculus) 6480464 silybin inhibits the reaction [Urethane results in increased secretion of FGF2 protein] CTD PMID:16788158 FGF2 Human urethane increases secretion ISO Fgf2 (Mus musculus) 6480464 Urethane results in increased secretion of FGF2 protein CTD PMID:16788158 FGF2 Human valdecoxib multiple interactions EXP 6480464 valdecoxib affects the reaction [Lipopolysaccharides results in increased secretion of FGF2 protein] CTD PMID:24431307 FGF2 Human valdecoxib affects secretion EXP 6480464 valdecoxib affects the secretion of FGF2 protein CTD PMID:24431307 FGF2 Human valproic acid increases expression ISO Fgf2 (Rattus norvegicus) 6480464 Valproic Acid results in increased expression of FGF2 mRNA and Valproic Acid results in increased expression of FGF2 protein CTD PMID:28693025 FGF2 Human valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of FGF2 mRNA CTD PMID:23179753 more ... FGF2 Human valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of FGF2 mRNA CTD PMID:25979313 FGF2 Human water increases expression EXP 6480464 Water results in increased expression of FGF2 mRNA CTD PMID:26800359 FGF2 Human zinc atom multiple interactions EXP 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of FGF2 mRNA CTD PMID:18593933 FGF2 Human zinc(0) multiple interactions EXP 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of FGF2 mRNA CTD PMID:18593933 FGF2 Human zoledronic acid decreases expression EXP 6480464 zoledronic acid results in decreased expression of FGF2 mRNA CTD PMID:24714768 FGF2 Human zoledronic acid multiple interactions EXP 6480464 zoledronic acid promotes the reaction [Gossypol results in decreased expression of FGF2 mRNA] CTD PMID:19825521